论文部分内容阅读
目的探讨新辅助化疗在乳腺癌治疗中的应用效果。方法将220例乳腺癌患者随机分为研究组和对照组各110例。所有患者接受常规对症治疗和密切护理,并行保乳手术,研究组联合新辅助化疗。比较2组临床疗效。结果研究组总有效率为79.1%高于对照组的59.1%,差异有统计学意义(P<0.05)。结论新辅助化疗治疗乳腺癌是一种行之有效的治疗方法,值得临床推广应用。
Objective To investigate the effect of neoadjuvant chemotherapy in the treatment of breast cancer. Methods 220 cases of breast cancer were randomly divided into study group and control group of 110 cases. All patients received conventional symptomatic treatment and close care, breast-conserving surgery in parallel, the study group combined neoadjuvant chemotherapy. The clinical efficacy of two groups were compared. Results The total effective rate was 79.1% in the study group and 59.1% in the control group, with significant difference (P <0.05). Conclusion Neoadjuvant chemotherapy for breast cancer is an effective treatment, which is worthy of clinical application.